Skip to main content
OpenTrials

Clinical trial condition

Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia

Explore clinical trials studying Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia trial results

Completed

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

NCT00381680

Conditions
B-cell Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 173 locations
View Trial Details

Related conditions